The following trials provide information to treat various types of gastrointestinal diseases, both for ongoing and completed clinical trials. For more information on this therapy area please click here.
- collapse A multicentre, randomised, double-blind, parallel study to investigate the efficacy and safety of Helicobacter pylori eradication one-week therapy with triple combination of Omeprazole, Amoxicillin and Clarithromycin in Japanese peptic ulcer patients (Phase IV post-marketing clinical study)
- collapse A fixed versus flexible budesonide dosing schedule in Crohn's disease for maintenance of remission (FREEDOM).
- collapse A Multicenter, Randomized, Double-Blind, Double-Dummy, Parallel-Group Efficacy Study Comparing 8 Weeks of Treatment with Esomeprazole Magnesium (40 mg qd) to Lansoprazole (30 mg qd) for the Healing of Erosive Esophagitis in Patients with Moderate or Severe Erosive Esophagitis
- collapse A Randomized, Open-Label, 2-Way Crossover Study to Evaluate the Effects of Timing of Dosing in Relation to Food on the Pharmacokinetics of Esomeprazole Magnesium (NEXIUM) in Healthy Subjects
- collapse A Multi-Centered, Phase IV, Post-Marketing, Prospective, Randomized, Double-Blind Study Comparing Esomeprazole Magnesium 40 mg Once Daily versus Lansoprazole 30 mg Twice Daily in Symptom Control of Subjects with Persistent Symptoms of Gastroesophageal Reflux Disease While on 30 mg Once Daily Lansoprazole Therapy
- collapse A Multicenter, Double-blind, Placebo-controlled Study to Evaluate the Effects of Esomeprazole 40 mg bid on the Signs and Symptoms of Chronic Posterior Laryngitis in Patients with Suspected Laryngopharyngeal Reflux
- collapse Trans GERD: Efficacy and Tolerability of Esomeprazol in Patients Under Ordinary Medical Care Conditions
- collapse Effect of treatment with budesonide CIR capsules and prednisolone on bone density, bone metabolism and osteoporosis in patients with Crohn's disease, measured using dual energy X-ray absorptiometry (MATRIX).
- collapse A multicentre, randomised, double-blind, parallel-group, comparative study to compare the efficacy and safety of D961H 20 mg once daily oral administration with omeprazole 10 mg and D961H 10 mg once daily oral administration in maintenance treatment in patients with healed reflux esophagitis
- collapse A Long Term Safety study of D961H Capsule (20mg o.d.) for the Prevention of Gastric and/or Duodenal Ulcers Associated with Daily NSAID Use in Patients at Risk
